Targeting clonal heterogeneity in treatment-refractory Glioblastoma with novel and empiric immunotherapies

Sheila K. Singh, MD PhD FRCS(C)
Associate Professor of Surgery, McMaster University, Canada Research Chair in Human Cancer Stem Cell Biology
Thursday, January 11, 2018 - 4:00pm
PMH, 610 University Avenue, 6th Floor Auditorium, Rm 6-604
Dr. Thomas Kislinger
OCI Seminar Series